Maintaining Innovation and Safe Technologies Act

This bill tells the federal health agency to spell out how Medicare will pay for certain remote health devices that use artificial intelligence. It focuses on tools like continuous glucose monitors that send data to a doctor and use AI to help adjust care. The agency must publish clear guidance using its usual channels by January 1, 2027, and the rules would apply under Medicare Part B for these kinds of devices. A plain-language summary confirms that the guidance will cover payment requirements for AI-powered remote monitoring devices that transmit information to health care providers.

Key points:

• Who is affected: People with Medicare who use remote monitoring devices, their doctors, and device makers.
• What changes: Medicare will issue clear payment guidance for AI-enabled devices that send data to providers (for example, glucose monitors with AI features).
• When: Guidance must be issued by January 1, 2027.